|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-9-17
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1715-5258
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
401; author reply 401-2
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17872667-Abnormalities, Drug-Induced,
pubmed-meshheading:17872667-Drug Therapy, Combination,
pubmed-meshheading:17872667-Female,
pubmed-meshheading:17872667-Humans,
pubmed-meshheading:17872667-Infant, Newborn,
pubmed-meshheading:17872667-Interferon-alpha,
pubmed-meshheading:17872667-Male,
pubmed-meshheading:17872667-Paternal Exposure,
pubmed-meshheading:17872667-Pregnancy,
pubmed-meshheading:17872667-Pregnancy Outcome,
pubmed-meshheading:17872667-Pregnancy Trimester, First,
pubmed-meshheading:17872667-Recombinant Proteins,
pubmed-meshheading:17872667-Ribavirin,
pubmed-meshheading:17872667-Risk Assessment,
pubmed-meshheading:17872667-Teratogens
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Inadequate numbers.
|
|
pubmed:publicationType |
Letter,
Comment
|
